BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11059992)

  • 1. Immediate effects of risperidone on cortico-striato-thalamic loops and the hippocampus.
    Liddle PF; Lane CJ; Ngan ET
    Br J Psychiatry; 2000 Nov; 177():402-7. PubMed ID: 11059992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia.
    Lane CJ; Ngan ET; Yatham LN; Ruth TJ; Liddle PF
    J Psychiatry Neurosci; 2004 Jan; 29(1):30-7. PubMed ID: 14719048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients.
    Smesny S; Langbein K; Rzanny R; Gussew A; Burmeister HP; Reichenbach JR; Sauer H
    Schizophr Res; 2012 Jul; 138(2-3):164-70. PubMed ID: 22516552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia.
    Molina V; Reig S; Pascau J; Sanz J; Sarramea F; Gispert JD; Luque R; Benito C; Palomo T; Desco M
    Psychiatry Res; 2003 Nov; 124(3):163-75. PubMed ID: 14623068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients.
    Goghari VM; Smith GN; Honer WG; Kopala LC; Thornton AE; Su W; Macewan GW; Lang DJ
    Schizophr Res; 2013 Sep; 149(1-3):149-55. PubMed ID: 23830856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study.
    Kraguljac NV; White DM; Hadley N; Hadley JA; Ver Hoef L; Davis E; Lahti AC
    Schizophr Bull; 2016 Jul; 42(4):1046-55. PubMed ID: 26873890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics.
    Kumari V; Antonova E; Geyer MA; Ffytche D; Williams SC; Sharma T
    Int J Neuropsychopharmacol; 2007 Aug; 10(4):463-77. PubMed ID: 16923324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change.
    Ngan ET; Lane CJ; Ruth TJ; Liddle PF
    J Neurol Neurosurg Psychiatry; 2002 Jan; 72(1):106-10. PubMed ID: 11784835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia.
    Miller DD; Andreasen NC; O'Leary DS; Watkins GL; Boles Ponto LL; Hichwa RD
    Biol Psychiatry; 2001 Apr; 49(8):704-15. PubMed ID: 11313038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of psychosis with temporal lobe epilepsy: SPECT changes with treatment.
    Oner O; Unal O; Deda G
    Pediatr Neurol; 2005 Mar; 32(3):197-200. PubMed ID: 15730902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal subregion volume changes associated with antipsychotic treatment in first-episode psychosis.
    Rhindress K; Robinson DG; Gallego JA; Wellington R; Malhotra AK; Szeszko PR
    Psychol Med; 2017 Jul; 47(10):1706-1718. PubMed ID: 28193301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.
    Remington G; Mamo D; Labelle A; Reiss J; Shammi C; Mannaert E; Mann S; Kapur S
    Am J Psychiatry; 2006 Mar; 163(3):396-401. PubMed ID: 16513859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.
    Honey GD; Bullmore ET; Soni W; Varatheesan M; Williams SC; Sharma T
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13432-7. PubMed ID: 10557338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging studies - differential action of typical and atypical antipsychotics in a network perspective.
    Vernaleken I; Cumming P; Gründer G
    Pharmacopsychiatry; 2008 Sep; 41 Suppl 1():S60-9. PubMed ID: 18756422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcortical modulation of attentional control by second-generation antipsychotics in first-episode psychosis.
    Ikuta T; Robinson DG; Gallego JA; Peters BD; Gruner P; Kane J; John M; Sevy S; Malhotra AK; Szeszko PR
    Psychiatry Res; 2014 Feb; 221(2):127-34. PubMed ID: 24120303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?
    Borgwardt SJ; Smieskova R; Fusar-Poli P; Bendfeldt K; Riecher-Rössler A
    Psychol Med; 2009 Nov; 39(11):1781-2. PubMed ID: 19476691
    [No Abstract]   [Full Text] [Related]  

  • 17. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study.
    Dazzan P; Morgan KD; Orr K; Hutchinson G; Chitnis X; Suckling J; Fearon P; McGuire PK; Mallett RM; Jones PB; Leff J; Murray RM
    Neuropsychopharmacology; 2005 Apr; 30(4):765-74. PubMed ID: 15702141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aripiprazole versus risperidone on brain activation during planning and social-emotional evaluation in schizophrenia: A single-blind randomized exploratory study.
    Liemburg EJ; van Es F; Knegtering H; Aleman A
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):112-119. PubMed ID: 28558941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral blood flow changes in very-late-onset schizophrenia-like psychosis with catatonia before and after successful treatment.
    Tsujino N; Nemoto T; Yamaguchi T; Katagiri N; Tohgi N; Ikeda R; Shiraga N; Mizumura S; Mizuno M
    Psychiatry Clin Neurosci; 2011 Oct; 65(6):600-3. PubMed ID: 22003993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D2 receptor occupancy by risperidone: implications for the timing and magnitude of clinical response.
    Catafau AM; Corripio I; Pérez V; Martin JC; Schotte A; Carrió I; Alvarez E
    Psychiatry Res; 2006 Dec; 148(2-3):175-83. PubMed ID: 17059881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.